Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
CEFUROXIME 750MG (VIAL)
07/29/2025
08/05/2025
IV
440mg
Q8H
PCAP
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: